Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
EXERCISE OPTION PERIOD 1 FOR THE SHORT TERM VISN 15 CONTRACT FOR PURCHASE OF WHOLE BLOOD GLUCOSE TESTING SUPPLIES is a federal award for 255-Network Contract Office 15 (36C255) held by Roche Diagnostics Corp. Estimated value $150K ($92K obligated). Current period of performance ends May 31, 2023. Last award drew 1 bidder. Place of performance: INDIANAPOLIS IN.
EXERCISE OPTION PERIOD 1 FOR THE SHORT TERM VISN 15 CONTRACT FOR PURCHASE OF WHOLE BLOOD GLUCOSE TESTING SUPPLIES
Recompete timing
PublicCurrent PoP ended May 31, 2023 (1178 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25522N0294?
36C25522N0294 (Exercise OPTION PERIOD 1 for the) is a 255-Network Contract Office 15 (36C255) award with a potential value of $150K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C255-22-N-0294?
36C255-22-N-0294 is the dashed form of PIID 36C25522N0294 (Exercise OPTION PERIOD 1 for the), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25522N0294?
255-Network Contract Office 15 (36C255) awarded 36C25522N0294 to Roche Diagnostics Corp (potential $150K).
Who is the incumbent on 36C25522N0294?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2023.
When does Roche Diagnostics Corp’s 36C25522N0294 come up for recompete?
SCOUT tracks a period-of-performance end of May 31, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.